Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunotherapy
Biotech
Biopsies illuminate potential of Candel's prostate cancer drug
Five months after revealing results of a prostate cancer trial, Candel has shown more data from the study, bolstering the value of CAN-2409.
Kevin Dunleavy
May 22, 2025 6:57pm
BioNTech makes £1B commitment to expand UK research, build HQ
May 20, 2025 11:15am
Immutep's LAG-3 agent posts 'impressive' survival data
May 5, 2025 10:37am
Biocon accused of IP theft to create cancer biotech Bicara
Oct 24, 2024 11:04am
UCLA scoops $120M gift for immunology and immunotherapy site
Aug 28, 2024 9:25am
Genentech to close cancer immunology research department
Aug 16, 2024 11:08am
